Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · Real-Time Price · USD
4.040
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Checkpoint Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-56.24-51.85-62.62-56.67-23.08
Upgrade
Stock-Based Compensation
15.252.92.923.142.78
Upgrade
Other Operating Activities
8.714.156.757.635.52
Upgrade
Change in Accounts Receivable
-0.07-0.0600.01
Upgrade
Change in Accounts Payable
1.6-3.57-4.3818.77-0.83
Upgrade
Change in Other Net Operating Assets
-0.420.7-0.170.83-0.94
Upgrade
Operating Cash Flow
-31.1-47.59-57.55-26.31-16.55
Upgrade
Issuance of Common Stock
35.1944.7617.6241.2833.28
Upgrade
Repurchase of Common Stock
---1.7--
Upgrade
Other Financing Activities
-2.41-4.31-1.03-1.01-2.03
Upgrade
Financing Cash Flow
32.7840.4514.8940.2731.25
Upgrade
Net Cash Flow
1.68-7.14-42.6713.9614.7
Upgrade
Levered Free Cash Flow
-18.6-43.27-26.97-12.72-13.56
Upgrade
Unlevered Free Cash Flow
-18.6-43.27-26.97-12.72-13.56
Upgrade
Change in Net Working Capital
-1.2513.58-6.56-19.61.84
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q